Amid record spike in daily coronavirus infections, India's drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced vaccineswithin three working days from the date of submission, the government said on Thursday.
The CentralDrug Authority, CDSCO, will process applications for registration certificates (registration of overseas manufacturing site and product; in this case COVID vaccine) and import license within three working days from the date of approval of restricted use in emergency situation.
The CDSCO issued detailed guidelines specifying regulatory pathway for approval of foreign approved COVID-19 vaccines after thecentral government on Tuesday decided